Technical considerations for the use of CRISPR/Cas9 in hematology research
Year: 2017
Type: review
Source: Experimental Hematology
Institutions: Baylor College of Medicine, Stanford University, Lund University, Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, German Cancer Research Center, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Institute for Stem Cell Biology and Regenerative Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: Burroughs Wellcome Fund, Doris Duke Charitable Foundation, American Society of Hematology, Charles H. Hood Foundation, Cooley's Anemia Foundation, Cancer Prevention and Research Institute of Texas, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences
OpenAlex ID: W2742080296